SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-028632
Filing Date
2008-05-01
Accepted
2008-05-01 07:03:17
Documents
7
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a08-11234_110q.htm 10-Q 939535
2 EX-3.2 a08-11234_1ex3d2.htm EX-3.2 94263
3 EX-12.1 a08-11234_1ex12d1.htm EX-12.1 38155
4 EX-31.1 a08-11234_1ex31d1.htm EX-31.1 16637
5 EX-31.2 a08-11234_1ex31d2.htm EX-31.2 14562
6 EX-32.1 a08-11234_1ex32d1.htm EX-32.1 7417
7 EX-32.2 a08-11234_1ex32d2.htm EX-32.2 7424
  Complete submission text file 0001104659-08-028632.txt   1119376
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 08791912
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1